MUM-2-B Support Breast Milk Production

Country: Australia

Language: English

Source: Department of Health (Therapeutic Goods Administration)

Active ingredient:

cupric oxide, Quantity: 313 microgram (Equivalent: copper, Qty 250 microgram); calcium folinate, Quantity: 270 microgram (Equivalent: folinic acid, Qty 250 microgram); betacarotene, Quantity: 350 microgram; ferrous fumarate, Quantity: 32.02 mg (Equivalent: iron, Qty 10 mg); pyridoxine hydrochloride, Quantity: 1.215 mg (Equivalent: pyridoxine, Qty 1 mg); heavy magnesium oxide, Quantity: 8.64 mg (Equivalent: magnesium, Qty 5.18 mg); Trigonella foenum-graecum, Quantity: 40 mg (Equivalent: Trigonella foenum-graecum, Qty 400 mg); ascorbic acid, Quantity: 15 mg; nicotinamide, Quantity: 3.5 mg; calcium pantothenate, Quantity: 2.73 mg (Equivalent: pantothenic acid, Qty 2.5 mg); phytomenadione, Quantity: 500 microgram; colecalciferol, Quantity: 3 microgram; thiamine nitrate, Quantity: 870 microgram; potassium iodide, Quantity: 144 microgram (Equivalent: iodine, Qty 110 microgram); riboflavin, Quantity: 700 microgram; calcium carbonate, Quantity: 50 mg (Equivalent: calcium, Qty 20 mg); choline bitartrate, Quantity: 7.5 mg; d-alpha-tocopheryl acid succinate, Quantity: 4.01 mg (Equivalent: d-alpha-tocopherol, Qty 4.85 IU); zinc oxide, Quantity: 2.49 mg (Equivalent: zinc, Qty 2 mg); manganese sulfate monohydrate, Quantity: 620 microgram (Equivalent: manganese, Qty 200 microgram); cyanocobalamin, Quantity: 125 microgram; Biotin, Quantity: 15 microgram

Available from:

Kissun Pharmaceuticals Pty Ltd

Pharmaceutical form:

Capsule, hard

Composition:

Excipient Ingredients: purified water; hypromellose; magnesium stearate; colloidal anhydrous silica; titanium dioxide; chlorophyllin-copper complex; gellan gum

Administration route:

Oral

Therapeutic indications:

Traditionally used in Western herbal medicine to Maintain/support breast milk production/lactation

Product summary:

Visual Identification: ;

Authorization status:

Listed

Authorization date:

2023-02-23